08372.HK
Grand Brilliance Group Holdings Limited
HKSE · Healthcare · Medical - Distribution · HK
HKD 0.16
+10.34%Year over year
Reported trailing growth
- Revenue
- +32.2%
- EBITDA
- +28.1%
- EBIT
- -36.1%
- EPS
- +11.9%
- Free cash flow
- -100.0%
- Operating cash flow
- -100.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +9.5%
- EBITDA
- -12.8%
- EBIT
- -4.0%
- Net income
- +3.6%
- EPS
- +3.4%
- Free cash flow
- -100.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026